<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74101</article-id><article-id pub-id-type="doi">10.7554/eLife.74101</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-256253"><name><surname>Avet</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256254"><name><surname>Mancini</surname><given-names>Arturo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-256680"><name><surname>Breton</surname><given-names>Billy</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-256681"><name><surname>Le Gouill</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-256255"><name><surname>Hauser</surname><given-names>Alexander Sebastian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1098-6419</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256252"><name><surname>Normand</surname><given-names>Claire</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-103507"><name><surname>Kobayashi</surname><given-names>Hiroyuki</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4965-0883</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-256682"><name><surname>Gross</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-256683"><name><surname>Hogue</surname><given-names>Mireille</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-256684"><name><surname>Lukasheva</surname><given-names>Viktoriya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-256685"><name><surname>St-Onge</surname><given-names>Stéphane</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256686"><name><surname>Carrier</surname><given-names>Marilyn</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256687"><name><surname>Héroux</surname><given-names>Madeleine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256688"><name><surname>Morissette</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-170530"><name><surname>Fauman</surname><given-names>Eric B</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-256689"><name><surname>Fortin</surname><given-names>Jean-Philippe</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-256690"><name><surname>Schann</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" corresp="yes" id="author-256691"><name><surname>Leroy</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" corresp="yes" id="author-241273"><name><surname>Gloriam</surname><given-names>David E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4299-7561</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-164270"><name><surname>Bouvier</surname><given-names>Michel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1128-0100</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf15"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Molecular Medicine</institution>, <institution>University of Montreal</institution>, <addr-line><named-content content-type="city">Montréal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution>Domain Therapeutics North America</institution>, <addr-line><named-content content-type="city">Montréal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Department of Drug Design and Pharmacology</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution content-type="dept">Internal Medicine Research Unit</institution>, <institution>Pfizer Worldwide Research</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Pfizer Global R&amp;D</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Domain Therapeutics</institution>, <addr-line><named-content content-type="city">Illkirch-Strasbourg</named-content></addr-line>, <country>France</country></aff><aff id="aff7"><institution>Domain Therapeutics</institution>, <addr-line><named-content content-type="city">llkirch-Strasbourg</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31137"><name><surname>Weis</surname><given-names>William I</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>xleroy@domaintherapeutics.com</email> (XL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>david.gloriam@sund.ku.dk</email> (DG);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>michel.bouvier@umontreal.ca</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74101</elocation-id><history><date date-type="received"><day>21</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Avet et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Avet et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74101-v1.pdf"/><abstract><p>The recognition that individual GPCRs can activate multiple signaling pathways has raised the possibility of developing drugs selectively targeting therapeutically relevant ones. This requires tools to determine which G proteins and barrestins are activated by a given receptor. Here, we present a set of BRET sensors monitoring the activation of the 12 G protein subtypes based on the translocation of their effectors to the plasma membrane (EMTA). Unlike most of the existing detection systems, EMTA does not require modification of receptors or G proteins (except for G<sub>s</sub>). EMTA was found to be suitable for the detection of constitutive activity, inverse agonism, biased signaling and polypharmacology. Profiling of 100 therapeutically relevant human GPCRs resulted in 1,500 pathway-specific concentration-response curves and revealed a great diversity of coupling profiles ranging from exquisite selectivity to broad promiscuity. Overall, this work describes unique resources for studying the complexities underlying GPCR signaling and pharmacology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bouvier</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>FDN-148431</award-id><principal-award-recipient><name><surname>Bouvier</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R218-2016-1266</award-id><principal-award-recipient><name><surname>Gloriam</surname><given-names>David E</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R313-2019-526</award-id><principal-award-recipient><name><surname>Gloriam</surname><given-names>David E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>NNF18OC0031226</award-id><principal-award-recipient><name><surname>Gloriam</surname><given-names>David E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Arturo Mancini, was employee of Domain Therapeutics North America during this research.</p></fn><fn fn-type="conflict" id="conf3"><p>Billy Breton, was employee of Domain Therapeutics North America during this research. Has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf4"><p>Christian Le Gouill, has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf5"><p>Claire Normand, was employee of Domain Therapeutics North America during this research.</p></fn><fn fn-type="conflict" id="conf6"><p>Hiroyuki Kobayashi, has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf7"><p>Florence Gross, was employee of Domain Therapeutics North America during this research.</p></fn><fn fn-type="conflict" id="conf8"><p>Mireille Hogue, has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf9"><p>Viktoriya Lukasheva, has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf10"><p>Sandra Morissette, SM was employee of Domain Therapeutics North America during this research.</p></fn><fn fn-type="conflict" id="conf11"><p>Eric B Fauman, is employee and shares holders of Pfizer.</p></fn><fn fn-type="conflict" id="conf12"><p>Jean-Philippe Fortin, is employee and shares holders of Pfizer.</p></fn><fn fn-type="conflict" id="conf13"><p>Stephan Schann, is employee and is part of the management of Domain Therapeutics.</p></fn><fn fn-type="conflict" id="conf14"><p>Xavier Leroy, is employee and is part of the management of Domain Therapeutics.</p></fn><fn fn-type="conflict" id="conf15"><p>Michel Bouvier, is the president of Domain Therapeutics scientific Has filed patent application (US20200256869A1) related to the biosensors used in this work and the technology has been licensed to Domain Therapeutics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 2, 4, 5, 6 and 7 and associated figure supplements. Supplementary Table 1  contains the numerical data used to generate Figure 2-figure supplement 1 and Figure 2-figure supplement 3. Supplementary Table 2  contains the numerical data used to generate figure 3.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hauser AS</collab><collab>Avet C</collab><collab>Normand C</collab><collab>Mancini A</collab><collab>Inoue A</collab><collab>Bouvier M</collab><collab>Gloriam DE</collab></person-group><year iso-8601-date="2021">2021</year><source>G protein selectivity - a unified meta-analysis</source><ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.07.459250v1">https://www.biorxiv.org/content/10.1101/2021.09.07.459250v1</ext-link><comment>Accompanying dataset paper in BioRXiv (https://doi.org/10.1101/2021.09.07.459250) and www.gpcrdb.org (https://doi.org/10.1093/nar/gkab852)</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-74101-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>